AIDS 2012: Looking to the Future in HIV and TB

AIDS 2012: Looking to the Future in HIV and TB

For more information on this session, including access to speaker presentations, please see the conference Programme-at-a-Glance.

Over the last few years, there have been tremendous advances in knowledge of prevention and treatment of tuberculosis in persons living with HIV as well as scale up of services. Nevertheless, the burden of tuberculosis remains enormous in persons living with HIV, and new approaches are needed. The purpose of this session is to provide an overview of the latest developments in HIV and tuberculosis. Specifically, the session will cover the state of the art in TB diagnostics, prevention, and treatment; emerging data on delivery of HIV/TB care: and TB vaccine development. The session will include a special commentary of tuberculosis in the HIV infected pediatric population.

Introduction

TB Prevention:  New Data, New Approaches, New Challenges

  • A. Grant, United Kingdom

New TB Diagnostics and Drugs:  Potential and Pitfalls

  • Richard Chaisson, United States

Integrating HIV and TB Delivery:  Models, Results and Prospect

  • Haileyesus Getahun, Switzerland

TB Vaccines:  What is on The Horizon?

  • Thomas Evans, United States

Special Commentary: Pediatric HIV and TB

  • Whoopi Goldberg, United States

Event Date

Jul 27, 2012



KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.